Covista CVSA
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$1.77M (7 inflow days, 13 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 46.1% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 4.79% to 8.47% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Stephen Beard | Individual/Insider | 2026/Q3 | +66,842 | 1.3% |
| FMR | Mutual Fund | 2026/Q3 | +1,068,851 | 12.9% |
| American Century Investment Management | Mutual Fund | 2026/Q3 | +338,020 | 1.2% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +98,371 | 2.0% |
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +75,711 | 0.2% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +72,249 | 5.6% |
| Boston Partners Global Investors, Inc. | Mutual Fund | 2026/Q3 | +71,795 | 1.9% |
| JPMorgan Chase & Co. | Public Company | 2026/Q3 | +69,300 | 0.3% |
| Edgestream Partners, L.P. | Hedge Fund | 2026/Q3 | +66,094 | 0.2% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +57,839 | 0.3% |
| Fisher Investments | Mutual Fund | 2026/Q3 | +35,974 | 1.6% |
| FMR | Mutual Fund | 2026/Q3 | +335,432 | 10.4% |
| Stephen Beard | Individual/Insider | 2026/Q3 | +75,148 | 1.3% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +276,752 | 2.3% |
| BlackRock | Mutual Fund | 2026/Q3 | +250,818 | 16.1% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 11 Nov 2026 | William Burke | Independent Director | Sale to Issuer | -362 | $119.00 | 10,061 |
| 11 Nov 2026 | Michael Malafronte | Lead Independent Director | Sale to Issuer | -487 | $119.00 | 135,613 |
| 11 Nov 2026 | Kenneth Phelan | Independent Director | Sale to Issuer | -363 | $119.00 | 19,473 |
| 11 Nov 2026 | Donna Hrinak | Independent Director | Sale to Issuer | -318 | $119.00 | 7,900 |
| 11 Nov 2026 | Emily Chiu | Independent Director | Sale to Issuer | -110 | $119.00 | 149 |
| 11 Nov 2026 | Betty Vandenbosch | Independent Director | Sale to Issuer | -390 | $119.00 | 2,194 |
| 11 Nov 2026 | Scott Liles | Chief Strategy & Performance Officer and President of Medical and Veterinary | Sale to Issuer | -350 | $119.00 | 7,921 |
| 11 Nov 2026 | Michael Betz | Chief Growth & Innovation Officer, Senior VP and President of Walden University | Sale to Issuer | -838 | $119.00 | 32,571 |
| 11 Nov 2026 | Douglas Beck | Senior VP of Institutional Support Services, General Counsel & Corporate Secretary | Sale to Issuer | -314 | $119.00 | 30,103 |
| 11 Nov 2026 | Georgette Kiser | Independent Director | Sale to Issuer | -391 | $119.00 | 17,090 |
| 11 Nov 2026 | Robert Phelan | Senior Vice President | Sale to Issuer | -629 | $119.00 | 50,289 |
| 11 Nov 2026 | Manjunath Gangadharan | Vice President | Sale to Issuer | -93 | $119.00 | 3,757 |
| 11 Nov 2026 | Sara Hill | Chief Human Resources Officer | Sale to Issuer | -254 | $119.00 | 4,688 |
| 11 Nov 2026 | William Krehbiel | Independent Director | Sale to Issuer | -390 | $119.00 | 15,913 |
| 11 Nov 2026 | Megan Noel | Senior VP & Chief Corporate Affairs Officer | Sale to Issuer | -329 | $119.00 | 413 |
| 11 Nov 2026 | Leslie Storms | Independent Director | Sale to Issuer | -85 | $119.00 | 174 |
| 10 Nov 2026 | William Burke | Independent Director | Other Acquisition | +1,255 | $119.55 | 1,255 |
| 10 Nov 2026 | Michael Malafronte | Lead Independent Director | Other Acquisition | +1,255 | $119.55 | 1,255 |
| 10 Nov 2026 | Kenneth Phelan | Independent Director | Other Acquisition | +1,255 | $119.55 | 1,255 |
| 10 Nov 2026 | Donna Hrinak | Independent Director | Other Acquisition | +1,255 | $119.55 | 1,255 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 2,816,263 | 8.5% | 8.2 |
| 15 Oct 2026 | 2,778,598 | 8.2% | 9.9 |
| 30 Sep 2026 | 2,541,398 | 7.5% | 6.1 |
| 15 Sep 2026 | 1,937,678 | 5.7% | 6.5 |
| 31 Aug 2026 | 1,771,806 | 5.2% | 4.9 |
| 14 Aug 2026 | 1,629,629 | 4.8% | 4.5 |
No comments yet — be the first to weigh in on CVSA.
Sign in to join the discussion.